Search

Your search keyword '"Barbouche, Mohamed‑Ridha"' showing total 315 results

Search Constraints

Start Over You searched for: Author "Barbouche, Mohamed‑Ridha" Remove constraint Author: "Barbouche, Mohamed‑Ridha"
315 results on '"Barbouche, Mohamed‑Ridha"'

Search Results

3. Regulatory T-cell dysfunction and cutaneous exposure to Staphylococcus aureus underlie eczema in DOCK8 deficiency

5. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity

6. Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry

12. Toward personalization of asthma treatment according to trigger factors

13. A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms

15. Contributors

16. Defects in intrinsic and innate immunity

17. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels

18. HBHA-IGRA and cytotoxic mediators release assays for the diagnosis of cervical tuberculous lymphadenitis

26. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes

27. Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings

28. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency

29. African Society for Immunodeficiency (Asid) Guidelines for Diagnosis and Management of Inborn Errors of Immunity in Africa: Core Concept, Development and Initial Results

30. Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry

34. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations

37. Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity

38. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988–2012)

40. COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis

43. COVID-19 in Tunisia (North Africa): IgG and IgG subclass antibody responses to SARS-CoV-2 according to disease severity

44. COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the general population of the capital city Tunis

48. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes.

Catalog

Books, media, physical & digital resources